Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-03-06 Purchase | 2025-03-06 5:53 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $5.015 | $50,150 | 2,295,731 (Direct) | View |
2025-03-05 Purchase | 2025-03-05 5:19 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $5.02 | $50,200 | 2,285,731 (Direct) | View |
2025-03-03 Purchase | 2025-03-04 4:45 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $4.705 | $47,050 | 2,275,731 (Direct) | View |
2025-02-28 Purchase | 2025-02-28 5:30 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $4.76 | $47,600 | 2,361,730 (Direct) | View |
2025-02-27 Purchase | 2025-02-27 4:13 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $4.76 | $47,600 | 2,351,730 (Direct) | View |
2025-02-26 Purchase | 2025-02-26 4:46 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $4.765 | $47,650 | 2,341,730 (Direct) | View |
2025-02-25 Purchase | 2025-02-25 7:38 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 10,000 | $4.464 | $44,640 | 2,331,730 (Direct) | View |
2024-03-04 Sale | 2024-03-06 4:47 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 55,172 | $4.193 | $231,339 | 1,871,730 (Direct) | View |
2023-03-02 Sale | 2023-03-06 6:25 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 44,964 | $6.2404 | $280,594 | 1,476,902 (Direct) | View |
2022-12-05 Sale | 2022-12-07 5:58 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 95,900 | $10.62 | $1,018,282 | 1,482,231 (Direct) | View |
2022-03-01 Sale | 2022-03-02 9:27 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 37,096 | $11.16 | $413,959 | 1,627,766 (Direct) | View |
2021-11-30 Sale | 2021-12-02 4:31 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 96,200 | $16.25 | $1,563,623 | 1,346,538 (Direct) | View |
2021-03-08 Sale | 2021-03-09 5:15 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 175,000 | $18 | $3,150,053 | 1,221,062 (Direct) | View |
2021-03-01 Sale | 2021-03-03 6:41 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 22,685 | $18.38 | $416,905 | 1,396,062 (Direct) | View |
2020-12-11 Sale | 2020-12-15 4:24 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 125,252 | $13.04 | $1,633,510 | 1,458,593 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-03-01 Tax Withholding | 2025-03-04 4:45 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 95,999 | $4.76 | 2,275,731 (Direct) | View |
2025-02-18 Option Award | 2025-02-20 7:45 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 450,000 | $0 | 2,321,730 (Direct) | View |
2024-02-16 Option Award | 2024-02-21 4:52 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 450,000 | $0 | 1,926,902 (Direct) | View |
2023-02-16 Option Award | 2023-02-21 6:10 pm | N/A 2033-02-15 | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 390,000 | $0 | 1,796,866 (Direct) | View |
2022-12-05 Exercise | 2022-12-07 5:58 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 150,000 | $3.12 | 1,482,231 (Direct) | View |
2022-12-05 Exercise | 2022-12-07 5:58 pm | N/A 2022-12-06 | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 150,000 | $0 | 1,482,231 (Direct) | View |
2022-02-28 Option Award | 2022-03-02 9:27 pm | N/A 2032-02-27 | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 390,000 | $0 | 1,627,766 (Direct) | View |
2021-11-30 Exercise | 2021-12-02 4:31 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 150,000 | $4.88 | 1,346,538 (Direct) | View |
2021-11-30 Exercise | 2021-12-02 4:31 pm | N/A 2021-12-05 | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 150,000 | $0 | 1,346,538 (Direct) | View |
2021-02-24 Option Award | 2021-02-26 5:18 pm | N/A 2031-02-23 | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 390,000 | $0 | 1,693,747 (Direct) | View |
2020-12-11 Exercise | 2020-12-15 4:24 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 150,000 | $8.75 | 1,458,593 (Direct) | View |
2020-12-11 Exercise | 2020-12-15 4:24 pm | N/A 2020-12-15 | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO | 150,000 | $0 | 1,458,593 (Direct) | View |